Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Staphylococcus aureus
- The envelope of gram-positive bacteria
- Protein A
- Sortase A - anchoring proteins
- S. aureus sortase A mutants
- Sortase A cleavage of LPXTG peptides
- Sortase A catalyzed transpeptidation
- LPXTG peptide bound to sortase A
- Deposition of protein A in the envelope
- Protein A on the staphylococcal surface
- Signal peptides of staphylococcal surface proteins
- Distribution of surface proteins in cell wall envelope
- SPs address proteins to specific locations
- Protein traffic to the cell wall envelope of S. aureus
- Fate of S. aureus injected into mice bloodstream
- Abscess formation in the kidney of mice
- Architecture of day 2 lesions
- Architecture of day 5 lesions
- SEM of staphylococci in host tissues
- Sortase mutants cannot form abscesses
- Sortase A is essential for persistence in host
- Sortase mutants in renal tissue
- Surface abscesses in wt and srtA mutants
- Surface proteins involved in abscess formation
- What are the protective antigens of staphylococci?
- Surface proteins and protective immunity
- Vaccine against abscess with IsdAB/SdrDE
- Staphylococcal abscesses enable persistence
- Heme-iron transport in staphylococci
- Sortase B and the IsdC anchor structure
- Protein topologies in the cell wall of staphylococci
- Staphylococcal envelope associated proteins
- Eap and Emp
- Lack of envelope associated proteins
- Eap mutants form abscesses
- Emp mutants cannot form abscesses
- Distribution of Eap, Emp in abscess formation
- Eap and Emp vaccines
- Vaccine protection against lethal challenge
- S. aureus and human lung infections
- Staphylococcus aureus pneumonia in mice
- Murine pneumonia model
- Mechanisms of Hla assembly and function
- Hla is an essential virulence factor for S. aureus
- Active immunization with Hla
- Passive immunization with Hla antibodies
- Summary and acknowledgments
Topics Covered
- The envelope of gram-positive bacteria
- Anchoring proteins
- Signal peptides of staphylococcal surface proteins
- Protein traffic to the cell wall envelope of S. aureus
- Fate of S. aureus injected into mice bloodstream
- Abscess formation
- What are the protective antigens of staphylococci?
- Surface proteins and protective immunity
- Staphylococcal abscesses enable persistence
- Protein topologies in the cell wall of staphylococci
- Vaccine protection against lethal challenge
- S. aureus and human lung infections
- Active/passive immunization
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Schneewind, O. (2009, November 2). Molecular pathogenesis and prevention of Staphylococcus aureus infections [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 26, 2024, from https://doi.org/10.69645/VAKP3485.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. Olaf Schneewind has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Hide